Psychosis Mental and Behavioural Disorders Unspecified nonorganic psychosis
Conditions
Interventions
This single-blinded randomised controlled trial will address the efficacy of CR therapy using NEAR model by targeting processing speed in first episode psychosis. Participants’ cognition, functioning
Sponsors
Public Service Department of Malaysia
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. First-episode psychosis patients with schizophrenia, schizophreniform disorder or schizoaffective disorder at diagnosis and presenting with cognitive deficits 2. Young adults aged 18 to 40 3. Able to read and write in Malay and/or English 4. Written informed consent 5. Fulfil the criteria of cognitive measures, symptomatology and other functioning 6. The symptoms must have been present during the past year including other criteria
Exclusion criteria
Exclusion criteria: 1. Previous diagnosis of mental retardation, psychotic disorder related to a general medical condition or substance-induced psychotic disorder 2. Severe schizophrenia 3. History of any diagnosis of a serious developmental disorder 4. Significant ongoing neurological disorders including epilepsy 5. History of severe head injury 6. Concurrently undergoing other types of cognitive remediation therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive functioning, assessed by neurocognitive assessment through The Brief Assessment of Cognition in Schizophrenia (BACS) at baseline and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional outcomes, assessed using functional measures including Schizophrenia Cognition Rating Scale (SCoRS), Social Functioning Scale (SFS), Social and Occupational Functioning Assessment Scale (SOFAS) and Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) at baseline and 8 weeks | — |
Countries
Malaysia
Contacts
Public ContactNaniyati Shuib
Outcome results
None listed